Current Breast Cancer Reports

, Volume 1, Issue 1, pp 1–2

Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer

Clinical Trials Report

DOI: 10.1007/s12609-009-0001-9

Cite this article as:
Dang, C. Curr Breast Cancer Rep (2009) 1: 1. doi:10.1007/s12609-009-0001-9

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Department of Medicine, Memorial Sloan-Kettering Cancer CenterBreast Cancer Medicine ServiceNew YorkUSA